Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
albendazole | Oral liquid | 20 mg/mL | |
albendazole | Tablet | 200mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
anastrozole | Tablet | 1mg | |
azathioprine | Tablet | 50 mg | |
busulfan | Tablet | 2 mg | |
capecitabine | Tablet | 150 mg | |
capecitabine | Tablet | 500 mg | |
carboplatin | Injection | 150 mg | |
carboplatin | Injection | 450 mg | |
chlorambucil | Tablet | 2 mg | |
cisplatin | Injection | 1 mg/mL | |
cisplatin | Injection | 50 mg | |
cyclophosphamide | Injection | 1 g | |
cyclophosphamide | Injection | 200 mg | |
cyclophosphamide | Tablet | 50 mg | |
cyproterone | Tablet | 50mg (as acetate) | |
cytarabine | Injection | 20 mg/mL | |
docetaxel | Injection | 20 mg/ml | |
docetaxel | Injection | 40 mg/mL | |
doxorubicin | Injection | 2 mg/mL | |
doxorubicin | Solution for injection | 50 mg | |
epirubicin | Injection | 10mg (chlorohydrate) | |
epirubicin | Injection | 50mg (chlorohydrate) | |
fluorouracil | Injection | 25 mg/mL | |
fluorouracil | Injection | 50 mg/mL | |
goserelin | implant | 10.8 mg | |
goserelin | Injection | 3.6 mg | |
hydroxyurea | Capsule | 500 mg | |
hydroxyurea | Tablet | 1 g | |
melphalan | Tablet | 2 mg | |
mercaptopurine | Tablet | 50 mg | |
methotrexate | Solution for injection | 25 mg/ ml | |
methotrexate | Tablet | 2.5 mg | |
paclitaxel | Injection | 6 mg/mL | |
procarbazine | Tablet | 50 mg | |
tamoxifen | Tablet | 20 mg | |
vincristine | Injection | 1 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
edrophonium chloride | Injection | 10 mg/ml | |
galantamine film coated | Tablet (prolonged release) | 8 mg | |
neostigmine | Injection | 2.5 mg/ml | |
pyridostigmine | Tablet | 60 mg (bromide) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
atropine | Injection | 0.5 mg (sulphate) in 1-mL ampoule | |
benzhexol | Tablet | 2 mg | |
benzhexol | Tablet | 5 mg | |
benztropine mesylat | Injection | 1 mg/ml | |
benztropine mesylat | Tablet | 2 mg | |
diphenhydramine | Injection | 50 mg/mL | |
hyoscine butylbromide | Injection | 20 mg/ml in 1-mL ampoule | |
hyoscine butylbromide | Tablet | 10mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
dobutamine | Injection | 12.5 mg/mL | |
dopamine | Injection | 40 mg/ml | |
epinephrine (adrenaline) | Injection | 0.01% (1: 10000) | |
epinephrine (adrenaline) | Injection | 0.1% | |
norepinephrine | Solution for injection | 2 mg/ ml | |
pseudoephedrine + chlorpheniramine | Oral liquid | 30 mg/2 mg | |
pseudoephedrine + chlorpheniramine | Tablet | 60 mg/4 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
cisatracurium | Injection | 2 mg/ml | |
dantrolene | Injection | 20 mg (sodium) | |
pancuronium | Injection | 2 mg (bromuro)/mL | |
rocuronium bromide | Solution for injection | 50 mg/ 5 ml | |
suxamethonium | Injection | 20 mg/mL (chloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
clopidogrel | Tablet | 75 mg | |
enoxaparin | Injection | 20 mg | |
enoxaparin | Injection | 40 mg | |
enoxaparin | Injection | 60 mg | |
enoxaparin | Injection | 80 mg. | |
heparin sodium | Injection | 5000 U/ml | |
protamine sulfate | Injection | 50 mg | |
rivaroxaban | Tablet | 15 mg | |
rivaroxaban | Tablet | 20 mg | |
warfarin | Tablet | 0.5 mg (sodium salt) | |
warfarin | Tablet | 1 mg (sodium salt) | |
warfarin | Tablet | 2 mg (sodium salt) | |
warfarin | Tablet | 3 mg (sodium salt) | |
warfarin | Tablet | 5 mg (sodium salt) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ferrous salt | Oral liquid | 44 mg Fe/5ml | |
ferrous salt | Tablet | equivalent to 60 mg iron | |
ferrous salt + folic acid | Tablet | equivalent to 60 mg iron + 400 micrograms folic acid | |
iron sucrose | Injection | 20 mg/ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
erythropoetin | Injection | 2000 IU | |
erythropoetin | Injection | 4000 UI |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
atorvastatine | Tablet | 10 mg | |
atorvastatine | Tablet | 20 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
adenosine | Injection | 3 mg/mL | |
amiodarone | Oral liquid | 30 mg/mL | |
amiodarone | Tablet | 100 mg | |
digoxin | Injection | 0.5 mg in 2 mL ampoule | |
digoxin | Oral liquid | 50 micrograms/mL | |
digoxin | Tablet | 0.125 mg | |
digoxin | Tablet | 0.25 mg | |
filgrastim | Injection | 300 micrograms/0.5 mL in pre-filled syringe. | |
filgrastim | Injection | 480 micrograms/0.8 mL in pre-filled syringe | |
lignocaine HCI | Injection | 100 mg | |
lignocaine HCI | Injection | 2 g | |
propranolol | Injection | 1mg/ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amlodipine | Tablet | 10 mg | |
amlodipine | Tablet | 2.5 mg | |
amlodipine | Tablet | 5 mg | |
amlodipine + losartan | Tablet | 10 mg/ 50 mg | |
amlodipine + losartan | Tablet | 5 mg/ 50 mg | |
bendrofluazide | Tablet | 2.5 mg | |
captopril | Tablet | 12.5 mg | |
captopril | Tablet | 25 mg | |
carvedilol | Tablet | 12.5 mg | |
carvedilol | Tablet | 25 mg | |
carvedilol | Tablet | 3.125 mg | |
carvedilol | Tablet | 6.25 mg | |
chlorthalidone | Tablet | 12.5 mg | |
chlorthalidone | Tablet | 25 mg | |
diltiazem | Tablet (controlled release) | 180 mg | |
diltiazem | Tablet (controlled release) | 60 mg | |
hydralazine | Solution for injection | 20 mg/ ml | |
hydralazine | Tablet | 25 mg | |
hydralazine | Tablet | 50 mg | |
labetalol | Injection | 5mg/ml | |
labetalol | Tablet | 100 mg | |
labetalol | Tablet | 50 mg | |
lisinopril | Tablet | 10 mg | |
lisinopril | Tablet | 20 mg | |
lisinopril | Tablet | 5 mg | |
lisinopril + amlodipine | Tablet | 10 mg + 5 mg | |
lisinopril + hydrochlorothiazide | Tablet | 20 mg + 12.5 mg | |
losartan | Tablet | 100 mg | |
losartan | Tablet | 25 mg | |
losartan | Tablet | 50 mg | |
methyldopa | Tablet | 250 mg | |
methyldopa | Tablet | 500mg | |
metoprolol | Injection | 1 mg/ml | |
metoprolol | Tablet (prolonged release) | 25 mg (succinato) | |
metoprolol | Tablet (prolonged release) | 50 mg (succinato) | |
minoxidil | Tablet | 5 mg | |
propranolol | Tablet | 40mg | |
propranolol | Tablet | 80mg | |
telmisartan | Tablet | 40 mg | |
telmisartan + hidroclorotiazida | Tablet | 40 mg + 12.5 mg | |
terazosin | Tablet | 2 mg | |
terazosin | Tablet | 5 mg | |
verapamil | Injection | 2.5 mg/mL | |
verapamil | Tablet | 40 mg | |
verapamil | Tablet (prolonged release) | 240 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
glyceryl trinitrate | Injection | 0.5 mg/mL | |
glyceryl trinitrate | spray | 0.4 mg | |
glyceryl trinitrate | Tablet (sublingual) | 500 mcg | |
isosorbide dinitrate | Tablet | 10 mg | |
prostaglandin E | Injection | 500 mcg/ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
streptokinase | Powder for injection | 750,000 IU |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
halothane | Inhalation | N/A | |
isoflurane | Inhalation | N/A | |
ketamine | Injection | 10 mg/mL | |
ketamine | Injection | 50 mg/mL | |
nitrous oxide | Inhalation | N/A | |
oxygen | Inhalation (medicine gas) | N/A | |
propofol | Injection | 10 mg/mL | |
sevoflurane | Solution | 250ml (trifluoromethyl ethyl) | |
thiopental | Powder for injection | 1 g |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
acetylsalicylic acid | Tablet | 325 mg | |
acetylsalicylic acid | Tablet | 81mg | |
diclofenac | Injection | 25 mg (sodium)/mL | |
diclofenac | Suppository | 100 mg | |
diclofenac | Suppository | 12.5 mg | |
diclofenac | Suppository | 50 mg | |
diclofenac | Tablet (controlled release) | 75 mg | |
fentanyl | Injection | 50 mcg (citrate)/mL | |
fentanyl | Patch | 25 mcg/hr | |
fentanyl | Patch | 75 mcg/hr | |
ibuprofen | Suspension | 100 mg/5 mL | |
ibuprofen | Tablet | 400 mg | |
methadone | Tablet | 5mg | |
morphine | Injection | 15 mg/mL | |
morphine | Oral liquid | 10 mg/5 ml | |
morphine | Tablet (controlled release) | 30 mg | |
morphine sulfate | Oral solution | 20 mg/mL. | |
naproxen | Tablet | 500 mg | |
oxycodone | Tablet (prolonged release) | 5 mg | |
paracetamol | Injection | 1 g | |
paracetamol | Injection | 500 mg | |
paracetamol | Oral liquid | 125 mg/5 ml | |
paracetamol | Suppository | 125 mg | |
paracetamol | Suppository | 250 mg | |
paracetamol | Suppository | 500 mg | |
paracetamol | Tablet | 500 mg | |
paracetamol + codeine | Tablet | 500 mg/ 30 mg | |
pethidine | Injection | 100 mg/mL | |
pethidine | Injection | 50 mg/ml | |
remifentanil | Injection | 1 mg | |
remifentanil | Injection | 2 mg | |
tramadol | Capsule | 50 mg | |
tramadol | Injection | 50 mg (hydrochloride)/mL | |
tramadol | Tablet (prolonged release) | 100 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
carbamazepine | Oral liquid | 100 mg/5 ml | |
carbamazepine | Tablet (controlled release) | 200 mg | |
clonazepam | Tablet | 0.5 mg | |
clonazepam | Tablet | 2mg | |
divalproex sodium | Tablet (controlled release) | 250 mg | |
gabapentin | Capsule | 300 mg. | |
levetiracetam | Oral solution | 100 mg/ ml | |
levetiracetam | Tablet | 250 mg | |
levetiracetam | Tablet | 500 mg | |
magnesium sulfate | Injection | 50% | |
phenobarbital | Injection | 200 mg/mL (sodium) | |
phenobarbital | Oral liquid | 15 mg/5 mL | |
phenobarbitone | Tablet | 30 mg | |
phenobarbitone | Tablet | 60 mg | |
phenytoin | Injection | 50 mg/mL | |
phenytoin | Injection | 50 mg/mL in 5-mL vial (sodium salt) | |
phenytoin | Oral liquid | 30 mg/5 mL | |
phenytoin | Solid oral dosage form | 100 mg (sodium salt) | |
phenytoin | Suspension | 125 mg/5 ml | |
phenytoin | Tablet | 50 mg | |
valproic acid (sodium valproate) | Syrup | 200 mg/5 ml | |
valproic acid (sodium valproate) | Tablet (prolonged release) | 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amitriptyline | Tablet | 25 mg | |
amitriptyline | Tablet | 50 mg | |
chlorpromazine | Injection | 25 mg/ ml | |
chlorpromazine | Tablet | 100 mg | |
chlorpromazine | Tablet | 25 mg | |
clozapine | Tablet | 100mg | |
clozapine | Tablet | 25mg | |
fluoxetine | Capsule | 20 mg | |
fluphenazine | Injection | 25 mg (decanoate)/mL | |
haloperidol | Injection | 100 mg/mL (decanoate) | |
haloperidol | Injection | 5 mg/mL | |
haloperidol | Oral liquid | 2 mg/mL | |
haloperidol | Tablet | 10 mg | |
haloperidol | Tablet | 5 mg | |
imipramine | Tablet | 25 mg | |
lithium carbonate | Tablet | 300 mg | |
nortriptilina | Tablet | 25 mg | |
olanzapine | Tablet | 10 mg | |
olanzapine | Tablet | 5 mg | |
prochlorperazine | Tablet | 5 mg | |
risperidone | Tablet | 1mg | |
risperidone | Tablet | 2mg | |
risperidone | Tablet | 3mg | |
risperidone | Tablet | 4 mg | |
trifluoperazine | Tablet | 10 mg | |
trifluoperazine | Tablet | 5 mg | |
zuclopenthixol decanoate depot | Injection | 200 mg/ml | |
zuclopenthixol dehydrochloride | Tablet | 10 mg | |
zuclopenthixol dehydrochloride | Tablet | 2 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
methylphenidate | Tablet | 10 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
alprazolam | Tablet | 0.25 mg | |
diazepam | Injection | 10 mg in 2-mL ampoule | |
diazepam | Suppository | 10 mg | |
diazepam | Tablet | 5 mg | |
lorazepam | Injection | 1 mg/mL | |
lorazepam | Tablet | 1 mg | |
midazolam | Injection | 5 mg/mL | |
promethazine | Injection | 25mg (hydrochloride)/ml | |
trimeprazine | Oral liquid | 30 mg/5 mL | |
zolpidem | Tablet (controlled release) | 6.25 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
flumazenil | Injection | 100mcg/ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
chlorhexidine/ cetrimide | W/ V | 1.5%/ 15 % | |
ethanol | N/A | 95% | |
glutaraldehyde | Solution | 2% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
sodium bicarbonate | Injection | 8.4% | |
sodium bicarbonate | Tablet | 600 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
lactulose | N/A | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
calcium gluconate | Injection | 10% | |
calcium lactate | Tablet | 300 mg (or gluconate) | |
intraperitoneal dialysis solution (of appropriate composition) | Parenteral solution | N/A | |
oral rehydration salts | N/A | N/A | |
polygeline | Solution for IV infusion | 35g polygeline in 1000ml | |
potassium chloride | Injection | 15% | |
potassium chloride | Liquid | 7.5% | |
potassium chloride | Tablet | 600 mg | |
ringer lactate solution | Parenteral formulation | N/A | |
sodium chloride | Parenteral formulation | 0.45% | |
sodium chloride | Parenteral formulation | 0.9% (20 mL) | |
sodium chloride | Parenteral formulation | 0.9% (250 mL) | |
sodium chloride | Parenteral formulation | 0.9% (500 mL) | |
sodium polystrene sulphonate | N/A | (resin) | |
water for injection | N/A | 10-ml ampoules |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
dextrose | Injection | 10% | |
dextrose | Injection | 50% | |
dextrose | Solution for injection | 5% - 1000 mL. | |
dextrose | Solution for injection | 5% - 250 mL | |
glucose + ringer's lactate | Parenteral formulation | dextrose 5%/lactated ringers | |
glucose with sodium chloride | Injectable solution | 4% glucose, 0.18% sodium chloride (equivalent to Na+ 30 mmol/L, Cl- 30 mmol/L) | |
glucose with sodium chloride | Injectable solution | 5% glucose, 0.45% sodium chloride (equivalent to 75 mmol/L Na+ and 75 mmol/L Cl-) | |
glucose with sodium chloride | Injectable solution | 5% glucose, 0.9% sodium chloride (equivalent to 150 mmol/L Na+ and 150 mmol/L Cl-) | |
glucose with sodium chloride | Injectable solution | glucose 5%, sodium chloride 0.2% | |
total parenteral nutrition | N/A | Premixed |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
furosemide | Injection | 10 mg/ml | |
furosemide | Injection | 20 mg/mL | |
furosemide | Oral liquid | 1 mg/ mL | |
furosemide | Tablet | 40 mg | |
furosemide | Tablet | 80 mg | |
hydrochlorothiazide | Solid oral dosage form | 12.5 mg | |
hydrochlorothiazide | Solid oral dosage form | 25 mg | |
hydrochlorthiazide + triamterene | Tablet | 25 mg/ 50 mg | |
mannitol | Injectable solution | 20% | |
spironolactone | Tablet | 25 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
glycine | Solution | 1.5% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
allopurinol | Tablet | 100 mg | |
allopurinol | Tablet | 300 mg | |
colchicine | Tablet | 0.5mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
cough expectorant liquid | N/A | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
beractant | Solution for intratracheal administration | 25 mg/ ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
chlorphenamine | Injection | 10 mg/mL (maleate) | |
chlorphenamine | Oral liquid | 2mg/5ml | |
chlorphenamine | Tablet | 4mg | |
desloratidine | Oral liquid | 5mg/5mL | |
loratadine | Tablet | 10 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
azithromycin | Eye ointment | 1.5% | |
chloramphenicol | ear drops | 5% | |
chloramphenicol | Eye ointment | 1% | |
chloramphenicol | Solution (eye drops) | 0.5% | |
ciprofloxacin | Solution (eye drops) | 0.3% | |
erythromycin | Eye ointment | 0.5% | |
gentamicin | Solution (eye drops) | 0.3% | |
imidazole | ear drops | N/A | |
natamycin | Solution (eye drops) | 5% | |
tetracycline | Eye ointment | 1% (hydrochloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
antibiotic + steroid | ear drops | N/A | |
beclometasone | Nasal spray | 50 mcg | |
betamethasone | Solution | 0.1% (eye, ear drops) | |
betamethasone sodium phosphate + neomycin sulphate | Solution (eye drops) | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
acetazolamide | Tablet | 250 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
bupivacaine | Solution (eye drops) | N/A | |
proparacaine hcl eye | Solution (eye drops) | 0,5% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
atropine | Solution (eye drops) | 1% (sulfate) | |
cyclopentolate | Solution (eye drops) | 1% (hydrochloride) | |
homatropine | Solution (eye drops) | 2% | |
phenylephrine | Solution (eye drops) | 1% | |
tropicamide | Solution (eye drops) | 0.5% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
naphazoline + antazoline | Solution (eye drops) | 0.05%/ 0.5% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
betaxolol | Solution (eye drops) | 0.5% | |
dorzolamide | Solution (eye drops) | 2% | |
fluorescein | strips | N/A | |
latanoprost | Solution (eye drops) | 0.005% | |
timolol | Solution (eye drops) | 0.5% (maleate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
aluminum + magnesium hydroxide | Suspension | 1:1 | |
aluminum + magnesium hydroxide | Tablet | N/A | |
aluminum hydroxide | Tablet | 500 mg | |
calcium carbonate | Tablet | 650 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
dimenhydrinate | Injection | 50 mg/mL | |
dimenhydrinate | Suppository | 100 mg | |
dimenhydrinate | Suppository | 25 mg | |
dimenhydrinate | Suppository | 50 mg | |
dimenhydrinate | Tablet | 50 mg | |
ondansetron | Injection | 2 mg/ml | |
ondansetron | Oral liquid | 4 mg base/5 ml | |
ondansetron | Tablet | 4 mg | |
ondansetron | Tablet | 8 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
artificial tears | Solution (eye drops) | 0.3% to 1% | |
balanced salt | Solution | N/A | |
fluorescein | strips | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
mesalazine | Suppository | 500 mg | |
mesalazine | Tablet (prolonged release) | 500 mg | |
metoclopramide | Injection | 5 mg/ml (hydrochloride) | |
metoclopramide | Tablet | 10mg | |
misoprostol | Tablet | 200 mcg | |
omeprazole | Capsule (delayed release) | 20 mg | |
omeprazole | Injection | 40 mg | |
pantoprazole | Tablet | 40 mg | |
ranitidine | Injection | 25 mg/ml (hydrochloride) | |
ranitidine | Tablet | 150 mg | |
ranitidine | Tablet | 300 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
acetylcysteine | Oral liquid | 20% | |
charcoal, activated | Powder | N/A | |
desferrioxamine mesilate | Injection | 500 mg | |
dimercaprol | Injection | 100 mg/mL | |
fuller´s earth (Bentonite) | N/A | N/A | |
ipecac | Liquid | N/A | |
penicillamine | Capsule | 250 mg | |
pralidoxime | Injection | 1g | |
sodium calcium edetate | Injection | 200 mg/ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
glucagon | Injection | 1 mg/mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
dexamethasone | Injection | 4 mg/mL | |
dexamethasone | Solid oral dosage form | 0.5 mg | |
fludrocortisone | Tablet | 0.1 mg | |
hydrocortisone | Injection | 100 mg (as sodium succinate) | |
methylprednisolone | Injection | 500 mg (sodium succinate) | |
prednisolone | Oral liquid | 10 mg/5 mL (as sodium phosphate) | |
prednisolone | Tablet | 20 mg | |
prednisolone | Tablet | 5 mg | |
prednisolone + cinchocaine | Suppository | 0.19%/ 0.5% | |
triamcinolone | Injection | 40 mg/mL (acetonide) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
condoms | N/A | N/A | |
copper-containing device | N/A | T 380 mm2 | |
levonorgestrel | Tablet | 1.5 mg | |
levonorgestrel | Tablet | 30 micrograms | |
medroxyprogesterone acetate | Depot injection | 150 mg/mL in 1-mL vial | |
norethisterone | Tablet | 5mg | |
norethisterone enantate | Injection | 200 mg in 1-mL ampoule | |
norethisterone enantate + estradiol valerate | Injection | 50 mg/5 mg | |
norethisterone enantate + estradiol valerate | Tablet | 50 mcg/ 5 mcg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
vasopressin | Injection | 20 U/ ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
norethisterone | Tablet | 0.35 mg | |
norethisterone | Tablet | 5mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
carbimazole | Tablet | 20 mg | |
carbimazole | Tablet | 5 mg | |
levothyroxine | Tablet | 100 mcg (sodium salt) | |
levothyroxine | Tablet | 50 mcg (sodium salt) | |
propylthiouracil | Tablet | 50 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
bupivacaine | Injection | 0.25% (preservative free) | |
bupivacaine | Injection | 0.5% (hydrochloride) without preservant | |
bupivacaine | Injection | 0.5% (preservative free) | |
ethyl chloride (chloroethane) | spray | N/A | |
lidocaine | Dental cartridge | 2% (hydrochloride) | |
lignocaine + epinephrine | Injection | 1%/ 100, 000 | |
lignocaine + epinephrine | Injection | 2% / 1:100 000 | |
lignocaine HCI | Injection | 1% | |
lignocaine HCI | Injection | 2% | |
lignocaine HCI | Injection for spinal anaesthesia | 5% (heavy) | |
lignocaine HCI | jelly | 2% | |
lignocaine HCI | spray | 10% | |
lignocaine HCI | spray | 4% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ergometrine | Injection | 500 mcg/mL | |
oxytocin | Injection | 10 units/ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
anti-D immunoglobulin (human) | Solution for injection | 300 mcg | |
antitetanus immunoglobulin (human) | Injection | 250 UI | |
antitetanus immunoglobulin (human) | Solution for injection | 2500 IU | |
diphtheria antitoxin | Injection | 20 000 IU in vial | |
human normal immunoglobulin | Injection | 3g | |
human normal immunoglobulin | Injection | 6g |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
anti-hepatitis B immunoglobulin | N/A | N/A | |
BCG vaccine | Injection | N/A | |
diphtheria, tetanus toxoid | Injection | N/A | |
diphtheria, tetanus toxoid + pertussis vaccine | Injection | N/A | |
hepatitis B vaccine | Injection | 10mcg/0.5ml | |
hepatitis B vaccine | Injection | 20 mcg/mL | |
MMR vaccine | N/A | N/A | |
pentavalent vaccine | Injection | diphtheria-tetanu toxoid, whole cell pertussis, hepatitis B, H. influenzae b (Hib) | |
pneumococcal vaccine -23 | Solution for injection | N/A | |
poliomyelitis vaccine | Oral liquid | trivalent | |
tetanus antitoxin | N/A | N/A | |
typhoid vaccine | Injection | N/A | |
yellow fever vaccine | N/A | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
bacitracin | Ointment | N/A | |
benzoin | tincture | N/A | |
chlorhexidine | Cream | 1% | |
chlorhexidine | Solution | 5% (gluconate) | |
fusidic acid | Cream | 2% | |
iodine-povidone | Solution | 1% | |
iodine-povidone | Solution | 7.5% | |
silver sulfadiazine | Cream | 1% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
antifungal + steroid | Cream | N/A | |
framycetin | dressing | (sulphate) | |
imidazole | Vaginal cream | N/A | |
imidazole | Vaginal tablet | (pessary) | |
ketoconazole | Cream | 2% | |
ketoconazole | shampoo | 2% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
betamethasone | Cream | 0.1% | |
hydrocortisone | Cream | 1% | |
hydrocortisone | Ointment | 1% | |
hydrocortisone | Suppository | (hemorrhoidal) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
permethrin | Cream | 5% | |
permethrin | Solution | 1% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
aqueous | Cream | N/A | |
lubricating jelly sterile | Gel | N/A | |
podophyllin | Powder | N/A | |
silver nitrate | stick | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
beclometasone | Metered dose inhaler (aerosol) | 250 mcg (dipropionate) per dose | |
beclometasone | Metered dose inhaler (aerosol) | 50 micrograms (dipropionate) per dose | |
budesonide | Solution for inhalation | 250 mcg/ml | |
budesonide + formoterol | Metered dose inhaler (aerosol) | 160 mcg/ 4.5 mcg | |
budesonide + formoterol | Metered dose inhaler (aerosol) | 80 mcg/ 4.5 mcg | |
ipratropium bromide | Inhalation (aerosol) | 20 micrograms/metered dose | |
ipratropium bromide | Solution | 250 mcg/ ml | |
ipratropium bromide + salbutamol | Solution for inhalation | 0.5 mcg/ 2.5 mcg | |
salbutamol | Inhalation | 100 mcg/metered dose | |
salbutamol | respirator solution for use in nebulizers | 5 mg/mL | |
salbutamol | Tablet | 4 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
folic acid | Tablet | 1 mg | |
folic acid | Tablet | 5 mg | |
hydroxocobalamin | Injection | 1 mg/mL | |
pyridostigmine | Tablet | 50 mg | |
thiamine | Injection | 100 mg/mL | |
thiamine | Tablet | 100 mg (hydrochloride) | |
vitamin B complex | Injection | i.m./ i.v. | |
vitamin B complex | Oral liquid | N/A | |
vitamin B complex | Tablet | N/A | |
vitamin B1 | Injection | 100 mg | |
vitamin B1 | Tablet | 100 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ascorbic acid | Tablet | 250 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
alfacalcidol | Capsule | 1 mcg | |
alfacalcidol | Tablet | 0.25 mcg | |
calcitriol | Injection | 1 mcg/ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
phytomenadione | Injection | 1 mg/0.6 mL | |
phytomenadione | Injection | 10 mg/mL in 1-mL vial | |
phytomenadione | Tablet | 10 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
iron + multivitamin | Oral liquid | N/A | |
iron + multivitamin | Oral solution (drops) | N/A | |
iron + multivitamin | Tablet | N/A | |
multivitamins | Tablet | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ethambutol | Tablet | 400mg | |
isoniazid | Oral liquid | 50 mg/5 ml | |
isoniazid | Tablet | 150 mg | |
isoniazid | Tablet | 300mg | |
isoniazid + pyrazinamide + rifampicin | Tablet | 150mg / 500 mg/ 300 mg | |
isoniazid + rifampicin | Tablet | 150 mg + 300 mg | |
pyrazinamide | Tablet | 500 mg | |
rifampicin | Capsule | 150 mg | |
rifampicin | Capsule | 300 mg | |
rifampicin | Oral liquid | 100mg/5ml | |
streptomycin | Injection | 1g (sulfate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amikacin | Injection | 250 mg/mL in 2-mL vial | |
amoxicillin | Suspension | 125 mg/ 5 ml | |
amoxicillin | Suspension | 250 mg/5ml | |
amoxicillin | Tablet | 250 mg | |
amoxicillin | Tablet | 500 mg | |
amoxicillin + clavulanic acid | Injection | 1 gm/200 mg | |
amoxicillin + clavulanic acid | Injection | 600 mg | |
amoxicillin + clavulanic acid | Oral liquid | 125 mg amoxicillin + 31.25 mg clavulanic acid/5 ml | |
amoxicillin + clavulanic acid | Oral liquid | 250 mg amoxicillin + 62.5 mg clavulanic acid/5 ml | |
amoxicillin + clavulanic acid | Oral liquid | 400 mg amoxicillin + 57 mg clavulanic acid/ 5 mL | |
amoxicillin + clavulanic acid | Tablet | 500 mg (as trihydrate) + 125 mg (as potassium salt) | |
amphotericin B | Injection | 50 mg | |
ampicillin | Injection | 500 mg | |
azithromycin | Suspension | 200 mg/5 ml | |
azithromycin | Tablet | 500 mg | |
cefadroxil | Capsule | 500mg | |
cefadroxil | Oral liquid | 125 mg/5 mL | |
cefadroxil | Tablet | 125 mg | |
cefazolin | Injection | 1g | |
cefazolin | Injection | 500 mg | |
cefotaxime | Injection | 1 g | |
ceftazidime | Injection | 1 g | |
ceftriaxone | Injection | 1 g | |
ceftriaxone | Injection | 250 mg | |
cefuroxime | Injection | 1.5 g | |
cefuroxime | Injection | 750 mg | |
cefuroxime | Suspension | 125 mg/5 ml | |
cefuroxime | Tablet | 250 mg | |
chloramphenicol | Capsule | 250 mg | |
chloramphenicol | Powder for injection | 1 g | |
chloramphenicol | Suspension | 125 mg/5 mL | |
ciprofloxacin | Injection | 200 mg | |
ciprofloxacin | Tablet | 250 mg | |
ciprofloxacin | Tablet | 500 mg | |
clarithromycin | Tablet | 250mg | |
clindamycin | Capsule | 150 mg | |
clindamycin | Capsule | 300 mg | |
clindamycin | Injection | 150 mg/mL | |
cloxacillin | Injection | 500 mg | |
dicloxacillin | Capsule | 500mg (sodium) | |
dicloxacillin | Suspension | 125mg/5ml | |
doxycycline | Capsule | 100 mg | |
erythromycin | Injection | 500 mg | |
erythromycin | Powder for oral liquid | 200 mg/5 mL | |
erythromycin | Tablet | 250 mg | |
fluconazole | Injection | 50mg/ 25 mL | |
fluconazole | Tablet | 150 mg | |
fluconazole | Tablet | 200 mg | |
fluconazole | Tablet | 50 mg | |
gentamicin | Injection | 20 mg/ mL | |
gentamicin | Injection | 40 mg/ml | |
griseofulvin | Oral liquid | 125 mg/5 ml | |
imipenem + cilastatin | Injection | 500mg + 500mg | |
levofloxacin | Tablet | 500 mg | |
mesalazine | Tablet | 400 mg | |
miconazole | Oromucosal administration | 25 mg/mL | |
nystatin | Oral liquid | 100 000 IU/ml | |
piperacillin sodium + tazobactum sodium | Injection | 2 g (as sodium) + 250 mg (as sodium) in vial | |
piperacillin sodium + tazobactum sodium | Injection | 4.5 g | |
sulfasalazine | Tablet | 500 mg | |
terbinafine | Cream | 1% | |
terbinafine | Tablet | 125 mg | |
terbinafine | Tablet | 250mg | |
tobramycin | Injection | 40 mg/mL | |
vancomycin | Injection | 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
abacavir | Tablet | 300 mg | |
abacavir | Tablet (dispersible, scored) | 60 mg | |
abacavir (ABC) | Oral liquid | 20mg/ml | |
abacavir + lamivudine | Tablet | 600 mg (como sulfato) + 300 mg | |
abacavir + lamivudine | Tablet | 600mg + 300mg | |
atazanavir + ritonavir | Tablet | 300 mg + 100 mg | |
darunavir | Tablet | 600 mg | |
dolutegravir | Tablet | 50 mg | |
efavirenz (EFV or EFZ) | Capsule | 600 mg | |
efavirenz (EFV or EFZ) | Tablet (dispersible) | 100 mg | |
efavirenz + emtricitabine + tenofovir | Tablet | 600 mg + 200 mg + 300 mg | |
emtricitabine + tenofovir | Tablet | 200 mg + 300 mg | |
lamivudine (3TC) | Oral liquid | 50 mg/5 ml | |
lamivudine (3TC) | Tablet | 150 mg | |
lamivudine + nevirapine + zidovudine | Tablet | 150 mg + 200 mg + 300 mg | |
lamivudine + nevirapine + zidovudine | Tablet | 30 mg + 50 mg + 60 mg | |
lamivudine + zidovudine | Tablet | 150 mg + 300 mg | |
lamivudine + zidovudine | Tablet (dispersible, scored) | 30 mg + 60 mg | |
lopinavir + ritonavir (LPV/r) | Oral liquid | 80 + 20 mg/ml | |
lopinavir + ritonavir (LPV/r) | Tablet | 100 mg/ 25 mg | |
lopinavir + ritonavir (LPV/r) | Tablet | 200 mg/ 50 mg | |
nevirapine (NVP) | Oral suspension | 50 mg/5ml | |
nevirapine (NVP) | Tablet | 200 mg | |
raltegavir | Oral liquid | 100 mg | |
ritonavir | Solid oral dosage form | 100 mg | |
tenofovir | Tablet | 300 mg | |
zidovudine (ZDV or AZT) | Capsule | 300 mg | |
zidovudine (ZDV or AZT) | Oral liquid | 50 mg/5 mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
aciclovir | Oral liquid | 200 mg/5 mL | |
aciclovir | Tablet | 400 mg | |
ganciclovir | Powder for injection | 500 mg | |
valacyclovir | Tablet | 500mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
glibenclamide | Tablet | 2.5 mg | |
glibenclamide | Tablet | 5 mg | |
gliclazide | Tablet (prolonged release) | 30 mg | |
gliclazide | Tablet (prolonged release) | 60 mg | |
insulin 70/30 | Injection | 10 ml | |
insulin glargine | Injection | 100 UI/ml | |
insulin soluble | N/A | 100 units/ml | |
metformin | Tablet | 250 mg | |
metformin | Tablet | 500 mg | |
metformin | Tablet | 850 mg | |
metformin | Tablet (prolonged release) | 500 mg | |
NPH insulin (intermediate-acting insulin) | Injection | 100 IU/mL | |
sitagliptin | Tablet | 100 mg | |
sitagliptin | Tablet | 50 mg | |
sitagliptina + metformina | Tablet | 50 mg/ 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
chloroquine | Tablet | 150 mg base (as sulphate) | |
hydroxychloroquine | Tablet | 200 mg | |
mefloquine | Tablet | 250 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
co-trimoxazole | Injection | 96 mg/ml | |
co-trimoxazole | Oral suspension | SMT 200 mg + TMP 40 mg/ 5 ml | |
co-trimoxazole | Tablet | 480 mg | |
co-trimoxazole | Tablet | 960 mg | |
sulphasalazine | Tablet | 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
metronidazole | Injection | 5 mg/mL | |
metronidazole | Suppository | 1 g | |
metronidazole | Suspension | 250 mg/5 mL | |
metronidazole | Tablet | 250 mg | |
metronidazole | Tablet | 500 mg | |
sulfadoxine + pyrimethamine | Tablet | 500 mg + 25 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
nitrofurantoin | Tablet (controlled release) | 100 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
clofazimine | Solid oral dosage form | 50 mg | |
dapsone | Tablet | 100 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
cinacalcet | Tablet | 30 mg | |
leucovorina | Injection | 10mg/ mL | |
leucovorina | Tablet | 15 mg | |
levamisole | Tablet | 40 mg | |
levodopa + carbidopa | Tablet | 250 mg + 25 mg |